Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01057355

Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms

Status
Withdrawn
Phase
Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pancreatic cysts are common, and some pancreas cysts have malignant potential. Usual treatment of these cysts is either observation or surgical removal of part or all of the pancreas. Minimally invasive treatment via endoscopy has been described, using endoscopic ultrasound (EUS) guided ethanol injections. Such studies exclude cysts that communicate with the main pancreatic duct, to avoid burning the main pancreatic duct with ethanol. In this study, pancreas cysts communicating with the main pancreas duct are treated with ethanol via endoscopic retrograde cholangiopancreatography (ERCP) and/or EUS.

Detailed description

Subjects will undergo EUS and/or ERCP as outpatients. For cysts shown to communicate with the main pancreas duct, a balloon catheter will be placed in the main pancreatic duct via ERCP. The balloon catheter will isolate the cyst from the main pancreatic duct, allowing ethanol injections of the cyst. A pancreatic duct stent will be placed in some patients, requiring repeat endoscopy for removal at another time.

Conditions

Interventions

TypeNameDescription
PROCEDUREEUS and/or ERCP with ethanol injections of pancreatic cystLavage of cyst with 80% ethanol

Timeline

Start date
2010-01-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2010-01-27
Last updated
2014-09-19

Source: ClinicalTrials.gov record NCT01057355. Inclusion in this directory is not an endorsement.